Inmagic DB/Text WebPublisher PRO: 27 records

Your search found 27 VIDEOS, WORKSHOPS, and WEBINARS.

	Article (Peer-Reviewed)
	1.	A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence.
			Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
			Pharmacogenomics Journal 2018;18(1):173-179. [doi: 10.1038/tpj.2016.89].


	2.	Causes of Death and Expected Years of Life Lost Among Treated Opioid-Dependent Individuals in the United States and Taiwan.
			Chang, Kun-Chia ; Wang, Jung-Der ; Saxon, Andrew J. ; Matthews, Abigail G. ; Woody, George E. ; Hser, Yih-Ing
			International Journal of Drug Policy 2017;45:1-6. [doi: 10.1016/j.drugpo.2016.12.003].


	3.	Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone.
			Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
			Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].


	4.	Chronic Pain Among Patients with Opioid Use Disorder: Results from Electronic Health Records Data.
			Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Huang, David
			Journal of Substance Abuse Treatment 2017;77:26–30. [doi: 10.1016/j.jsat.2017.03.006].


	5.	High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System.
			Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
			Journal of Addiction Medicine 2017;11(4):315-319. [doi: 10.1097/ADM.0000000000000312].


	6.	Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial.
			Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
			Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].


	7.	Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study.
			Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
			Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].


	8.	Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories.
			Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
			American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].


	9.	Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study.
			Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
			Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].


	10.	Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females.
			Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
			Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].


	11.	Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial.
			Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
			Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].


	12.	HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial.
			Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
			Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].


	13.	An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans.
			Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
			Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].


	14.	Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology.
			Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
			Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].


	15.	Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START).
			Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
			Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..


	16.	Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial.
			Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
			Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].


	17.	From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network.
			Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
			Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].


	18.	Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead?
			Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
			Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].


	19.	Buprenorphine Tapering Schedule and Illicit Opioid Use.
			Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
			Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].


	20.	Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs.
			Saxon, Andrew J. ; McCarty, Dennis
			Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].

	Poster
	21.	Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users.
			Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
			Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.

	Presentation
	22.	Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START).
			Ling, Walter ; Saxon, Andrew J.
			Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.

	Video
	23.	Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange. [Blending Initiative Workshop]
			Ranney, Megan L. ; Saxon, Andrew J. ; Todd, Knox H. ; Babu, Kavita M. ; Boyer, Edward W. ; Ringwalt, Chris L. ; Neven, Darin E. ; Nelson, Lewis S. ; Graykoski, John J. ; D'Onofrio, Gail ; Zatzick, Douglas F. ; Cunningham, Rebecca M. ; Dunn, Christopher W. ; Bernstein, Edward ; Broderick, Kerryann B. ; Howard, Patricia K.
			Sponsored by the NIDA/SAMHSA Blending Initiative, American College of Emergency Physicians, and the Centers for Control and Prevention, Seattle, WA, October 13, 2013.


	24.	Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview.
			Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
			Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.

	Webinar
	25.	CTN Webinar: Developing Medication Assisted Treatment (MAT) Protocols.
			Saxon, Andrew J.
			Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 17, 2013.

	Workshop
	26.	Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange. [Blending Initiative Workshop]
			Ranney, Megan L. ; Saxon, Andrew J. ; Todd, Knox H. ; Babu, Kavita M. ; Boyer, Edward W. ; Ringwalt, Chris L. ; Neven, Darin E. ; Nelson, Lewis S. ; Graykoski, John J. ; D'Onofrio, Gail ; Zatzick, Douglas F. ; Cunningham, Rebecca M. ; Dunn, Christopher W. ; Bernstein, Edward ; Broderick, Kerryann B. ; Howard, Patricia K.
			Sponsored by the NIDA/SAMHSA Blending Initiative, American College of Emergency Physicians, and the Centers for Control and Prevention, Seattle, WA, October 13, 2013.


	27.	From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment of Opioid Dependence.
			Saxon, Andrew J. ; Woody, George E. ; Jacobs, Petra ; Crist, Richard C. ; Nurhidayat, Adhi Wibowo ; Hickman, Mathew ; Strang, John
			Blending Initiative Workshop sponsored by the National Institute on Drug Abuse (NIDA), the National Drug Abuse Treatment Clinical Trials Network (CTN), and the NIDA/SAMHSA Blending Initiative in collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia, PA, November 10, 2013.

Powered by DB/Text WebPublisher, from

Inmagic WebPublisher PRO